Eicosanoid regulation of angiogenesis: Role of endothelial arachidonate 12-lipoxygenase

Blood

Volumn 95, Issue 7, 2000, Pages 2304-2311

  Nie, Daotai ^a   Tang, Keqin ^a   Diglio, Clement ^a   Honn, Kenneth V ^a,b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONATE 12 LIPOXYGENASE; ARACHIDONIC ACID; BASIC FIBROBLAST GROWTH FACTOR; ICOSANOID; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ARACHIDONIC ACID METABOLISM; ARTICLE; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; VASCULAR ENDOTHELIUM;

EID: 0034176036     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v95.7.2304     Document Type: Article

References (49)

1. Hanahan D. Signaling vascular morphogenesis and maintenance. Science. 1997;277:48.
2. Folkman J, Shing Y. Angiogenesis. J Biol Chem. 1992;267:10,931.
3. Funk CD, Keeney DS, Oliw EH, Boeglin WE, Brash AR. Functional expression and cellular localization of a mouse epidermal lipoxygenase. J Biol Chem. 1996;271:23,338.
4. Kim JA, Gu JL, Natarajan R, Berliner JA, Nadler JL. A leukocyte type of 12-lipoxygenase is expressed in human vascular and mononuclear cells: evidence for up-regulation by angiotensin II. Arterioscler Thromb Vasc Biol. 1995;15:942.
5. Krieg P, Kinzig A, Ress-Loschke M, et al. 12-Lipoxygenase isoenzymes in mouse skin tumor development. Mol Carcinog. 1995;14:118.
6. Funk C, Funk LB, FitzGerald GA, Samuelsson B. Characterization of human 12-lipoxygenase-genes. Proc Natl Acad Sci U S A. 1992;89:3962.
7. Sasaki M, Hori MT, Hino T, Golub MS, Tuck ML. Elevated 12-lipoxygenase activity in the spontaneously hypertensive rat. Am J Hypertens. 1997; 10:371.
8. Setty BN, Chen D, O'Neal P, Littrell JB, Grosman MH, Stuart MJ. Eicosanoids in sickle cell disease: potential relevance of 12(S)-hydroxy-5,8,10,14-eicosatetraenoic acid to the pathophysiology of vaso-occlusion. J Lab Clin Med. 1998;131:344.
9. Wang MM, Reynaud D, Pace-Asciak CR. In vivo stimulation of 12(S)-lipoxygenase in the rat skin by bradykinin and platelet activating factor: formation of 12(S)-HETE and hepoxilins, and actions on vascular permeability. Biochem Biophys Acta. 1999;1436:354.
10. Katoh A, Ikeda H, Murohara T, Haramaki N, Ito H. Imaizumi T. Platelet-derived 12-hydroxyeicosatetraenoic acid plays an important role in mediating carine coronary thrombosis by regulating platelet glycoprotein IIb/IIIa activation. Circulation. 1998; 98:2891.
11. Gao X, Grignon DJ, Chbihi T, et al. Elevated 12-lipoxygenase mRNA expression correlates with advanced stage and poor differentiation of human prostate cancer. Urology. 1995;46:227.
12. Nie D, Hillman GG, Geddes T, et al. Platelet-type 12-lipoxygenase in a human prostate carcinoma stimulates angiogenesis and tumor growth. Cancer Res. 1998;58:4047.
13. Tang DG, Renaud C, Stojakovic S, Diglio CA, Porter A, Honn KV. 12(S)-HETE is a mitogenic factor for microvascular endothelial cells: its potential role in angiogenesis. Biochem Biophys Res Commun. 1995;211:462.
14. Dethlefsen SM, Shepro D, D'Amore PA. Arachidonic acid metabolites in bFGF-, PDGF-, and serum-stimulated vascular cell growth. Exp Cell Res. 1994;212:262.
15. Honda HM, Leitinger N, Frankel M, et al. Induction of monocyte binding to endothelial cells by MM-LDL: role of lipoxygenase metabolites. Arterioscler Thromb Vasc Biol. 1999;19:680.
16. Setty BN, Graeber JE, Stuart MJ. The mitogenic effect of 15- and 12-hydroxyeicosatetraenoic acid on endothelial cells may be mediated via diacylglycerol kinase inhibition. J Biol Chem. 1987;262: 17,613.
17. 3 integrins on ECs. Int J Cancer. 1993;54:102.
18. Tang DG, Chen YQ, Renaud C, Diglio CA, Honn KV. Protein kinase C-dependent effects of 12(S)-HETE on EC vitronectin receptor and fibronectin receptor. J Cell Biol. 1993;121:689.
19. 3 integrin: a post-transcriptional, PKC- and cytoskeleton-dependent process. Cancer Res. 1994;54:1119.
20. v by protein kinase C activator 12(S)-HETE. J Cell Sci. 1995; 108:2629.
21. 3 for angiogenesis. Science. 1994;264:569.
22. 3 antagonist promotes tumor regression by inducing apoptosis of angiogenic blood vessels. Cell. 1994;79:1157.
23. 3 blocks human breast cancer growth and angiogenesis in human skin. J Clin Invest. 1995;96:1815.
24. Chen YQ, Duniec ZM, Liu B, et al. Endogenous 12(S)-HETE production by tumor cells and its role in metastasis. Cancer Res. 1994;54:1574.
25. Liu B, Marnett U, Chaudhary A, et al. Biosynthesis of 12(S)-hydroxyeicosatetraenoic acid by B16 amelanotic melanoma cells is a determinant of their metastatic potential. Lab Invest. 1994;70: 314.
26. Diglio CA, Liu W, Grammas P, Giacomelli F, Wiener J. Isolation and characterization of cerebral resistance vessel endothelium in culture. Tissue Cell. 1993;25:833.
27. Liu B, Renaud C, Nelson K, et al. Protein-kinase-C inhibitor calphostin C reduces B16 amelanotic melanoma cell adhesion to endothelium and lung colonization. Int J Cancer. 1992;52:147.
28. Ito Y, Iwamoto Y, Tanaka K, Okuyama K, Sugioka Y. A quantitative assay using basement membrane extracts to study tumor angiogenesis in vivo. Int J Cancer. 1996;67:148.
29. Watanabe T, Medina JF, Haeggstrom JZ, Badmark O, Samuelsson B. Molecular cloning of a 12-lipoxygenase cDNA from rat brain. Eur J Biochem. 1993;212:605.
30. Sa G, Fox PL. Basic fibroblast growth factor-stimulated endothelial cell movement is mediated by a pertussis toxin-sensitive pathway regulating phospholipase A2 activity. J Biol Chem. 1994; 269:3219.
31. Kumar R, Yoneda J, Bucana CD, Fidler IJ. Regulation of distinct steps of angiogenesis by different angiogenic molecules. Int J Oncol. 1998;12:749.
32. Wheeler-Jones C, Abu-Ghazaleh R, Cospedal R, Houliston RA, Martin J, Zachary I. Vascular endothelial growth factor stimulates prostacyclin production and activation of cytosolic phospholipase A2 in endothelial cells via p42/p44 mitogen-activated protein kinase. FEBS Lett. 1997;420:28.
33. Fafeur V, Jiang ZP, Bohlen P. Signal transduction by bFGF, but not TGFβ1, involves arachidonic acid metabolism in endothelial cells. J Cell Physiol. 1991;149:277.
34. Bicknell R, Vallee BL. Angiogenin stimulates endothelial cell prostacyclin secretion by activation of phospholipase A2. Proc Natl Acad Sci U S A. 1989;163:902.
35. Seghezzi G, Patel S, Ren CJ, et al. Fibroblast growth factor-2 (FGF-2) induces vascular endothelial cells of forming capillaries: an autocrine mechanism contributing angiogenesis. J Cell Biol. 1998;141:1659.
36. Ito K, Abe T, Tomita M, et al. Anti-angiogenic activity of arachidonic acid metabolism inhibitors in angiogenesis model systems involving human microvascular endothelial cells and neovascularization in mice. Int J Cancer. 1993;55:660.
37. Kaji T, Miyamoto A, Yamamoto C, Fujiwara Y, Miyajima S, Koizumi F. Basic fibroblast growth factor-induced glycosaminoglycan production in cultured vascular endothelial cells results from enhanced protein synthesis mediated by the lipoxygenase pathway. Life Sci. 1997;60:873.
38. Patte C, Blanquet PR. Possible involvement of arachidonic acid metabolites in the synergistic action of endothelial mitogenesis by basic fibroblast growth factor and phorbol ester. Cell Mol Biol. 1992;38:429.
39. Jackson JR, Bolognese B, Mangar CA, Hubbard WC, Marshall LA, Winkler JD. The role of platelet activating factor and other lipid mediators in inflammatory angiogenesis. Biochim Biophys Acta. 1998;1392:145.
40. 3 integrins. Prostaglandins. 1993;45:249.
41. Honn KV, Tang DG, Grossi I, et al. Tumor cell-derived 12(S)-hydroxyeicosatetraenoic acid induces microvascular endothelial cell retraction. Cancer Res. 1994;54:565.
42. Romano M, Chen XS, Takahashi Y, Yamamoto S, Funk CD, Serhan CN. Lipoxin synthase activity of human platelet 12-lipoxygenase. Biochem J. 1993;296:127.
43. Sheppard KA, Greenberg SM, Funk CD, Romano M, Serhan CN. Lipoxin generation by human megakaryocyte-induced 12-lipoxygenase. Biochim Biophys Acta. 1992;1133:223.
44. Serhan CN, Sheppard KA. Lipoxin formation during human neutrophil-platelet interactions: evidence for the transformation of leukotriene A4 by platelet 12-lipoxygenase in vitro. J Clin Invest. 1990;85:772.
45. Dadaian M, Westlund P. Albumin modifies the metabolism of hydroxyeicosatetraenoic acids via 12-lipoxygenase in human platelets. J Lipid Res. 1999;40:940.
46. Salgado R, Vermeulen PB, Benoy I, et al. Platelet number and interleukin-6 correlate with VEGF but not with bFGF serum levels of advanced cancer patients. Br J Cancer. 1999;80:892.
47. Pinedo HM, Verheul HM, D'Amato RJ, Folkman J. Involvement of platelets in tumour angiogenesis? Lancet. 1998;352:1775.
48. Maloney JP, Silliman CC, Ambruso DR, Wang J, Tuder RM, Voelkel NF. In vitro release of vascular endothelial growth factor during platelet aggregation. Am J Physiol. 1998;275:H1054.
49. Honn KV, Tang DG, Crissman JD. Platelets and cancer metastasis: a causal relationship? Cancer Metastasis Rev. 1992;11:325.